CAN14

N/A

Report date: 2025/12/05 16:18:28

Base Information

Drug NameCAN14
Drug Alias NameCAN-14CAN14
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Interleukin-1 receptor accessory protein
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCantargia Ab
China Registration ClassN/A

Develop Information

Active CompaniesCantargia Ab
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A